The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Cytidine deaminase status as a predictive marker in patients with hematologic malignancies treated with azacytidine or cytarabine.
Cedric Mercier
No relevant relationships to disclose
Raphaelle Fanciullino
No relevant relationships to disclose
Cindy Serdjebi
No relevant relationships to disclose
Joseph Ciccolini
No relevant relationships to disclose
Bertrand Pourroy
No relevant relationships to disclose
Gerard Milano
No relevant relationships to disclose
Regis Costello
No relevant relationships to disclose
L'houcine Ouafik
No relevant relationships to disclose